Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Antiherpetic medication and incident dementia: Observational cohort studies in four countries

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Effect of intravenous alteplase on post-stroke depression in the WAKE UP trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Chronic migraine: Genetics or environment?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Barriers in access to dementia care in minority ethnic groups in Denmark: a qualitative study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Stress diagnoses in midlife and risk of dementia: a register-based follow-up study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Rotational care practices in minority ethnic families managing dementia: A qualitative study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Christian Schnier
  • Janet Janbek
  • Linda Williams
  • Tim Wilkinson
  • Thomas M Laursen
  • Gunhild Waldemar
  • Hartmut Richter
  • Karel Kostev
  • Richard Lathe
  • Jürgen G Haas
View graph of relations

BACKGROUND AND PURPOSE: Several epidemiological studies from Taiwan, all using the same data resource, found significant associations between herpes virus infection, antiherpetic medication, and subsequent dementia. We conducted a multicenter observational cohort study using health registry data from Wales, Germany, Scotland, and Denmark to investigate potential associations between antiherpetic medication and incident dementia, and also to comprehensively investigate such associations broken down according to medication type and dose, type of herpes virus, and dementia subtype.

METHODS: A total of 2.5 million individuals aged 65 years or more were followed up using linked electronic health records in four national observational cohort studies. Exposure and outcome were classified using coded data from primary and secondary care. Data were analyzed using survival analysis with time-dependent covariates.

RESULTS: Results were heterogeneous, with a tendency toward decreased dementia risk in individuals exposed to antiherpetic medication. Associations were not affected by treatment number, herpes subtype, dementia subtype, or specific medication. In one cohort, individuals diagnosed with herpes but not exposed to antiherpetic medication were at higher dementia risk.

CONCLUSIONS: Short-term antiherpetic medication is not markedly associated with incident dementia. Because neither dementia subtype nor herpes subtype modified the association, the small but significant decrease in dementia incidence with antiherpetic administration may reflect confounding and misclassification.

Original languageEnglish
JournalEuropean Journal of Neurology
Volume28
Issue number6
Pages (from-to)1840-1848
Number of pages9
ISSN1351-5101
DOIs
Publication statusPublished - Jun 2021

    Research areas

  • Alzheimer disease, antiviral, cognitive decline, herpes, vascular dementia

ID: 65067596